Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rienk Offringa

Showing results (61-70 of 115) with videos related to

Pageof 12
Sort By:
Cancer Research|August 4, 2004
Human papillomavirus type 16-positive cervical cancer is associated with impaired CD4+ T-cell immunity against early antigens E2 and E6Annemieke de Jong, Mariëtte I E van Poelgeest, Jeanette M van der Hulst, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 20, 2007
Characterization of antigen-specific immune responses induced by canarypox virus vaccinesRinke Bos, Suzanne van Duikeren, Thorbald van Hall, et al.
International Journal of Cancer|November 13, 2004
Rapid enrichment of human papillomavirus (HPV)-specific polyclonal T cell populations for adoptive immunotherapy of cervical cancerAnnemieke de Jong, Jeanette M van der Hulst, Gemma G Kenter, et al.
Nature Communications|May 3, 2020
Proimmunogenic impact of MEK inhibition synergizes with agonist anti-CD40 immunostimulatory antibodies in tumor therapyDaniel Baumann, Tanja Hägele, Julian Mochayedi, et al.
Arthritis and Rheumatism|May 15, 2003
CD25+ cell depletion hastens the onset of severe disease in collagen-induced arthritisMary E Morgan, Roger P M Sutmuller, Hendrik J Witteveen, et al.
EMBO Molecular Medicine|February 19, 2015
A high-throughput RNAi screen for detection of immune-checkpoint molecules that mediate tumor resistance to cytotoxic T lymphocytesNisit Khandelwal, Marco Breinig, Tobias Speck, et al.
Journal for Immunotherapy of Cancer|June 3, 2025
Enhanced mutanome analysis towards the induction of neoepitope-reactive T-cell responses for personalized immunotherapy of pancreatic cancerMichael Volkmar, Dana Hoser, Claudia Lauenstein, et al.
Science Signaling|May 14, 2020
Phosphoproteomics of CD2 signaling reveals AMPK-dependent regulation of lytic granule polarization in cytotoxic T cellsVanessa Zurli, Tommaso Montecchi, Raphael Heilig, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 9, 2002
In vivo triggering through 4-1BB enables Th-independent priming of CTL in the presence of an intact CD28 costimulatory pathwayLinda Diehl, Geertje J D van Mierlo, Annemieke T den Boer, et al.
Human Immunology|February 1, 2003
Competition-based cellular peptide binding assays for 13 prevalent HLA class I alleles using fluorescein-labeled synthetic peptidesJan H Kessler, Bregje Mommaas, Tuna Mutis, et al.
Pageof 12

Showing results (61-70 of 115) with videos related to

Sort By:
Pageof 12
Cancer Research|August 4, 2004
Human papillomavirus type 16-positive cervical cancer is associated with impaired CD4+ T-cell immunity against early antigens E2 and E6Annemieke de Jong, Mariëtte I E van Poelgeest, Jeanette M van der Hulst, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 20, 2007
Characterization of antigen-specific immune responses induced by canarypox virus vaccinesRinke Bos, Suzanne van Duikeren, Thorbald van Hall, et al.
International Journal of Cancer|November 13, 2004
Rapid enrichment of human papillomavirus (HPV)-specific polyclonal T cell populations for adoptive immunotherapy of cervical cancerAnnemieke de Jong, Jeanette M van der Hulst, Gemma G Kenter, et al.
Nature Communications|May 3, 2020
Proimmunogenic impact of MEK inhibition synergizes with agonist anti-CD40 immunostimulatory antibodies in tumor therapyDaniel Baumann, Tanja Hägele, Julian Mochayedi, et al.
Arthritis and Rheumatism|May 15, 2003
CD25+ cell depletion hastens the onset of severe disease in collagen-induced arthritisMary E Morgan, Roger P M Sutmuller, Hendrik J Witteveen, et al.
EMBO Molecular Medicine|February 19, 2015
A high-throughput RNAi screen for detection of immune-checkpoint molecules that mediate tumor resistance to cytotoxic T lymphocytesNisit Khandelwal, Marco Breinig, Tobias Speck, et al.
Journal for Immunotherapy of Cancer|June 3, 2025
Enhanced mutanome analysis towards the induction of neoepitope-reactive T-cell responses for personalized immunotherapy of pancreatic cancerMichael Volkmar, Dana Hoser, Claudia Lauenstein, et al.
Science Signaling|May 14, 2020
Phosphoproteomics of CD2 signaling reveals AMPK-dependent regulation of lytic granule polarization in cytotoxic T cellsVanessa Zurli, Tommaso Montecchi, Raphael Heilig, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 9, 2002
In vivo triggering through 4-1BB enables Th-independent priming of CTL in the presence of an intact CD28 costimulatory pathwayLinda Diehl, Geertje J D van Mierlo, Annemieke T den Boer, et al.
Human Immunology|February 1, 2003
Competition-based cellular peptide binding assays for 13 prevalent HLA class I alleles using fluorescein-labeled synthetic peptidesJan H Kessler, Bregje Mommaas, Tuna Mutis, et al.
Pageof 12